Caspase substrates

Cell Death and Differentiation

Volumn 14, Issue 1, 2007, Pages 66-72

  Timmer, J C ^a,b   Salvesen, G S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; ENZYME PRECURSOR; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; NUCLEASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BID; PROTEINASE; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AMINO ACID SEQUENCE; APOPTOSIS; CANCER INHIBITION; CATALYSIS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ENZYME SYNTHESIS; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CASPASES; ENZYME ACTIVATION; HUMANS; PROTEINS; SUBSTRATE SPECIFICITY;

EID: 33845480311     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402059     Document Type: Review

References (69)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
2. Odake S, Kam CM, Narasimhan L, Poe M, Blake JT, Krahenbuhl O et al. Human and murine cytotoxic T lymphocyte serine proteases: Subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochem USA 1991; 30: 2217-2227.
3. Harris JL, Backes BJ, Leonetti F, Mahrus S, Ellman JA, Craik CS. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci USA 2000; 97: 7754-7759.
4. Stennicke HR, Renatus M, Meldal M, Salvesen GS. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 2000; 350: 563-568.
5. Hawkins CJ, Yoo SJ, Peterson EP, Wang SL, Vemooy SY, Hay BA. The Drosophila caspase DRONC cleaves following glutamate or aspartate and is regulated by DIAP1, HID, and GRIM. J Biol Chem 2000; 275: 27084-27093.
6. Vercammen D, van de Cotte B, De Jaeger G, Eeckhout D, Peter Casteels P, Vandepoele K et al. Type-II metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine. J Biol Chem 2004; 279: 45329-45336.
7. Chen JM, Rawlings ND, Stevens RA, Barrett AJ. Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. FEBS Lett 1998; 441: 361-365.
8. Thomberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997; 272: 17907-17911.
9. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D et al. Substrate specificities of caspase family proteases. J Biol Chem 1997; 272: 9677-9682.
10. Kato D, Boatright KM, Berger AB, Nazif T, Blum G, Ryan C et al. Activity-based probes that target diverse cysteine protease families. Nature Chem Biol 2005; 1: 33-38.
11. Faleiro L, Kobayashi R, Feamhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J 1997; 16: 2271-2281.
12. Denault JB, Salvesen GS. Human caspase-7 activity and regulation by lts N-terminal peptide. J Biol Chem 2003; 278: 34042-34050.
13. Read SH, Baliga BC, Ekert PG, Vaux DL, Kumar S. A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol 2002; 159: 739-745.
14. Tu S, McStay GP, Boucher LM, Mak T, Beers HM, Green DR. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol 2006; 8: 72-77.
15. Bode W, Brandstetter H, Mather T, Stubbs MT. Comparative analysis of haemostatic proteinases: Structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost 1997; 78: 501-511.
16. Lopez-Otin C, Overall CM. Protease degradomics: A new challenge for proteomics. Nat Rev Mol Cell Biol 2002; 3: 509-519.
17. Germain D, Dumas F, Vemet T, Bourbonnais Y, Thomas DY, Boileau G. The pro-region of the Kex2 endoprotease of Saccharomyces cerevisiae is removed by self-processing. FEBS Lett 1992; 299: 283-286.
18. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999; 6: 1028-1042.
19. Thomberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281: 1312-1316.
20. Stennicke HR, Salvesen GS. Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta 2000; 1477: 299-306.
21. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
22. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 2003; 10: 76-100.
23. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 2001; 410: 112-116.
24. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003; 11: 519-527.
25. Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, Salvesen GS. XIAP inhibits caspase-3 and -7 using two binding sites: Evolutionarily conserved mechanism of IAPs. EMBO J 2005; 24: 645-655.
26. Tenev T, Zachariou A, Wilson R, Ditzel M, Meier P. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat Cell Biol 2005; 7: 70-77.
27. Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281: 3254-3260.
28. Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG, Wu H. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature 2001; 410: 494-497.
29. Fisher AJ, Cruz W, Zoog SJ, Schneider CL, Friesen PD. Crystal structure of baculovirus P35: Role of a novel reactive site loop in apoptotic caspase inhibition. EMBO J 1999; 18: 2031-2039.
30. Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 1999; 96: 615-624.
31. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D. Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists. Cell 1999; 96: 625-634.
32. Otomo T, Sakahira H, Uegaki K, Nagata S, Yamazaki T. Structure of the heterodimeric complex between CAD domains of CAD and ICAD. Nat Struct Biol 2000; 7: 658-662.
33. Woo EJ, Kim YG, Kim MS, Han WD, Shin S, Robinson H et al. Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell 2004; 14: 531-539.
34. Chai J, Wu C, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y. Crystal structure of a procaspase-7 zymogen. Mechanisms of activation and substrate binding. Cell 2001; 107: 399-407.
35. Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp R, Huber R et al. Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA 2001; 98: 14790-14795.
36. Hubbard SJ, Campbell SF, Thornton JM. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol 1991; 220: 507-530.
37. Sleath PR, Hendrickson RC, Kronheim SR, March CJ, Black RA. Substrate specificity of the protease that processes human inteleukin-1β. J Biol Chem 1990; 265: 14526-14528.
38. Boyd SE, Pike RN, Rudy GB, Whisstock JC, Garcia de la Banda M. PoPS: A computational tool for modeling and predicting protease specificity. J Bioinform Comput Biol 2005; 3: 551-585.
39. Backes C, Kuentzer J, Lenhof HP, Comtesse N, Meese E. GraBCas: A bioinformatics tool for score-based prediction of Caspase- and granzyme B-cleavage sites in protein sequences. Nucleic Acids Res 2005; 33: W208-W213.
40. Lohmuller T, Wenzler D, Hagemann S, Kiess W, Peters C, Dandekar T et al. Toward computer-based cleavage site prediction of cysteine endopeptidases. Biol Chem 2003; 384: 899-909.
41. Garay-Malpartida HM, Occhiucci JM, Alves J, Belizario JE. CaSPredictor: a new computer-based tool for caspase substrate prediction. Bioinformatics 2005; 21 (Suppl 1): I169-i176.
42. Yang ZR. Prediction of caspase cleavage sites using Bayesian bio-basis function neural networks. Bioinformatics 2005; 21: 1831-1837.
43. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
44. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 2004; 117: 773-786.
45. Van Damme P, Martens L, Van Damme J, Hugelier K, Staes A, Vandekerckhove J et al. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat Methods 2005; 2: 771-777.
46. Martin SJ, Green DR. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995; 82: 349-352.
47. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997; 91: 443-446.
48. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem, J 2004; 384: 201-232.
49. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998; 273: 27084-27090.
50. Bossy-Wetzel E, Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999; 274: 17484-17490.
51. Barry M, Heibein JA, Pinkoski MJ, Lee SF, Moyer RW, Green DR et al. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic: T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol 2000; 20: 3781-3794.
52. Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, Gross A. BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts. J Biol Chem 2003; 278: 10707-10715.
53. Chou BN, Borges HL, Chen TT, Masselli A, Hunton IC, Wang JY. Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol 2002; 4: 757-765.
54. Hell K, Saleh M, Crescenzo GD, O'Connor-McCourt MD, Nicholson DW. Substrate cleavage by caspases generates protein fragments with Smac/ Diablo-like activities. Cell Death Differ 2003; 10: 1234-1239.
55. Huang Y, Rich RL, Myszka DG, Wu H. Requirement of both the BIR2 and BIR3 domains for the relief of XIAP-mediated caspase inhibition by Smac. J Biol Chem 2003.
56. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998; 391: 96-99.
57. Liu X, Zou H, Widlak P, Garrard W, Wang X. Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1. J Biol Chem 1999; 274: 13836-13840.
58. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-347.
59. Gu Y, Samecki C, Aldape RA, Livingston DJ, Su MSS. Cleavage of poly(ADP-ribose) polymerase by interleukin-1-beta converting enzyme and its homologs TX and Nedd-2. J Bio Chem 1995; 270: 18715-18718.
60. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR et al. Yama/CPP32-beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-809.
61. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, Poider GG. Cleavage of automodified Poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 1999; 274: 28379-28384.
62. Petrilli V, Herceg Z, Hasse PO, Patel NS, Di Paola R, Cortes U et al. Noncleavable poly(ADP-ribose polymerase-1 regulates the inflammation response in mice. J Clin Invest 2004; 114: 1072-1081.
63. Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274: 8359-8362.
64. Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant Huntingtin. Cell 2006; 125: 1179-1191.
65. Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO et al. Depletion of wild-type Huntingtin in mouse models of neurologic diseases. J Neurochem 2003; 87: 101-106.
66. Lu C, Fu W, Salvesen GS, Mattson MP. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromol Med 2002; 1: 69-79.
67. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 2006; 103: 7130-7135.
68. Schweizer A, Brand C, Grutter MG. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem 2003; 278: 42441-42447.
69. Schecter I, Berger M. On the size of the active site in proteases. Biochem Biophys Res Commun 1967; 27: 157-162.